BBK Worldwide® Blog

Minimizing Clinical Trial Disruption from COVID-19

Posted by Elizabeth Gargill on Thu, Apr 2, 2020

BBK's Founding Principal and CEO Joan F. Bachenheimer discusses how BBK can help clinical trial sponsors respond to the immediate challenges resulting from the COVID-19 outbreak. 

Read More

Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer